The Women's Health Initiative: An unforgettable decade

May 31, 2012 in Health

The 10-year anniversary of the historic Women's Health Initiative (WHI) Hormone Therapy Trial report, which radically changed the practice of women's health, will be commemorated in July 2012. In anticipation of this event, two of the world's leading experts in women's health, menopause, and hormone therapy are releasing an editorial in the journal Menopause, providing their perspective on this epic study and the lessons learned over the past 10 years.

JoAnn Manson, MD, MPH, DrPH, from Brigham and Women's Hospital (BWH), and Lubna Pal, MBBS, MRCOG, MSc, from Yale University School of Medicine, note that the WHI's 10-year anniversary is a good time to reflect on the pendulum swings and dramatic evolution in our thinking about estrogen and hormone therapy (HT), which changed the lives of millions of . The authors state in their editorial, "The WHI is an historic trial that has changed clinical practice and, ultimately, has helped lead us towards a more rational interpretation of the place of hormone therapy in menopause management."

The WHI hormone trials were designed to assess the role of HT in the prevention of heart disease, as well as to evaluate the benefits and risks of HT when used for chronic disease prevention. The trials were done in ages 50-79 (with a mean age of 63) and tested the types of HT (Premarin and Prempro) that were in common use at the time the study started. The estrogen plus progestin trial was stopped three years early because of an increased risk of breast cancer, heart disease, and concerns that the overall risks exceeded the benefits. The estrogen-alone trial (in women with hysterectomy) showed fewer risks but was stopped one year early due to an increased risk of stroke. Estrogen-alone did not appear to increase or . In fact, estrogen-alone seemed to lower the risk of heart disease in younger women (in the 50-59 year age group) and seemed to have a favorable benefit-risk profile in that age group. However, the harmful findings in the in both HT trials tended to be extrapolated to younger women, resulting in dramatic (>70%) reductions in prescriptions for hormone therapy.

Manson, one of the principal investigators of the WHI since the start of the study and current president of the North American Menopause Society, said, "The WHI deserves credit for stopping the growing clinical practice of prescribing hormone therapy to older women who were at very high risk of . In fact, these women did not receive heart benefit from estrogen therapy and may even have suffered harm. Unfortunately, the findings in older women were extrapolated to newly menopausal healthy women who tended to have a favorable benefit to risk ratio with HT."

At least 70% of newly menopausal women have hot flashes and/or night sweats, and about 20% have moderate-to-severe symptoms that disrupt sleep and impair quality of life. Over the past 10 years, research from the WHI and other studies has provided a critical mass of evidence for the timing hypothesis, which suggests that younger women closer to the onset of menopause tend to have better outcomes on hormone therapy than older women who are distant from menopause onset. The are also more likely to have hot flashes and other menopausal symptoms, and thereby derive quality of life benefits. Manson said, "The recent findings highlight the importance of individualized care for women. The 'one size fits all' approach to decision making is no longer acceptable." Manson adds that it will also be important to understand whether different types and formulations of (such as patches, pills or lower doses of hormones) will have a different balance of benefits and risks.

Journal reference: Menopause search and more info website

Provided by Brigham and Women's Hospital search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

New rice contamination reported in China

Authorities are investigating rice mills in southern China following tests that found almost half of the staple grain in one of the country's largest cities was contaminated with a toxic metal.

Health created 4 minutes ago | popularity not rated yet | comments 0

Warning images for cigarette packs do not make a strong enough emotional impact

The warning images Brussels proposes to include on tobacco packages in order to reduce consumption do not make the desired impact on smokers because they only find some of them really unpleasant. So, if the ...

Health created 1 hour ago | popularity not rated yet | comments 0

Cancer and birth defects in Iraq: The nuclear legacy

Ten years after the Iraq war of 2003 a team of scientists based in Mosul, northern Iraq, have detected high levels of uranium contamination in soil samples at three sites in the province of Nineveh which, coupled with dramatically ...

Health created 1 hour ago | popularity not rated yet | comments 0

Dirty jokes the best medicine

When it comes to men's sexual health, dirty jokes may just be the best medicine. A QUT researcher is helping Family Planning Queensland (FPQ) use comedy and YouTube to deliver sexuality education to young ...

Health created 2 hours ago | popularity not rated yet | comments 0

Salt consumption in India: The need for data to initiate population-based prevention efforts

(Medical Xpress)—International researchers are studying the salt intake of Indian adults to provide vital new data to aid the development of a national salt reduction strategy.

Health created 2 hours ago | popularity not rated yet | comments 0


Study shows where scene context happens in our brain

In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...

New tumour-killer shows great promise in suppressing cancers

Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.

Analgesics prescribed more heavily to women than to men, study finds

Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is inf ...

New factor to control oncogene-induced senescence

An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...

Do men's and women's hearts burn fuel differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...

Asthma symptoms impair sleep quality and school performance in children

The negative effects of poorly controlled asthma symptoms on sleep quality and academic performance in urban schoolchildren has been confirmed in a new study.